Gero Tenderich
Gero Tenderich has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Barbara Lamp
Depts. of Thoracic and Cardiovascular Surgery and Cardiology
3 shared publicationsBert Hansky
Heart and Diabetes Center North Rhein-Westphalia, Ruhr-University Bochum , Bad Oeynhausen
3 shared publicationsDieter Horstkotte
Depts. of Thoracic and Cardiovascular Surgery and Cardiology
3 shared publicationsJürgen Vogt
Depts. of Thoracic and Cardiovascular Surgery and Cardiology
3 shared publicationsReiner Körfer
Heart Centre North Rhine Westphalia, University of Bochum , Bad Oeynhausen
3 shared publicationsHolger Güldner
Heart Centre North Rhine Westphalia, University of Bochum , Bad Oeynhausen
2 shared publications
Latest Publications
- 1 May 2015
- Published by Elsevier in Journal of Electrocardiology
- Vol. 48 (3) , 420-422
Diagnosis of obstructive coronary artery disease by cardiogoniometry: A field test in a real-life setting
- 1 May 2015
- Published by Elsevier in Journal of Electrocardiology
- Vol. 48 (3) , 420-422
Diagnosis of obstructive coronary artery disease by cardiogoniometry: A field test in a real-life setting
- Open Access
- 4 February 2014
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 46 (3) , 356-360
A monitoring and physiological control system for determining aortic valve closing with a ventricular assist device
Real-time monitoring of the aortic valve function and the loading state of the left ventricle (LV) during mechanical circulatory support is essential. Therefore, we developed a system that determines accurately the aortic valve closing moment based on integrals derived from the pump inlet pressure and the pump power [pressure-power area (PPA)]. A Deltastream diagonal pump was implanted in 10 healthy Rhoen sheep. Changes in ventricular volume and pressure in different assist levels were measured by a conductance catheter placed in the LV and were correlated with intrinsic pump signals, motor power, voltage and current. Measurements were obtained in the state of normal as well as decreased left ventricular contractility induced by β-blockers. Complete datasets were obtained in seven animals. The PPA-feedback signal reached its maximum at the speed of aortic valve closing. This was validated by pressure-volume (PV)-catheter measurements both at the baseline and in the state of decreased contractility. In both cases, zero-crossing occurred at the point of aortic valve closing speed. With this trial, we deliver the experimental basis for the development of an automatic feedback controller that would allow periodic speed changes in accordance with the loading state of the native ventricle and the opening state of the aortic valve. This would deliver real-time data to treating physicians and enable the establishment of a standard weaning protocol.
- 4 February 2014
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 46 (3) , 356-360
Open AccessA monitoring and physiological control system for determining aortic valve closing with a ventricular assist device
Real-time monitoring of the aortic valve function and the loading state of the left ventricle (LV) during mechanical circulatory support is essential. Therefore, we developed a system that determines accurately the aortic valve closing moment based on integrals derived from the pump inlet pressure and the pump power [pressure-power area (PPA)]. A Deltastream diagonal pump was implanted in 10 healthy Rhoen sheep. Changes in ventricular volume and pressure in different assist levels were measured by a conductance catheter placed in the LV and were correlated with intrinsic pump signals, motor power, voltage and current. Measurements were obtained in the state of normal as well as decreased left ventricular contractility induced by β-blockers. Complete datasets were obtained in seven animals. The PPA-feedback signal reached its maximum at the speed of aortic valve closing. This was validated by pressure-volume (PV)-catheter measurements both at the baseline and in the state of decreased contractility. In both cases, zero-crossing occurred at the point of aortic valve closing speed. With this trial, we deliver the experimental basis for the development of an automatic feedback controller that would allow periodic speed changes in accordance with the loading state of the native ventricle and the opening state of the aortic valve. This would deliver real-time data to treating physicians and enable the establishment of a standard weaning protocol.
- 16 November 2005
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 53 (S 3) , P_6
Inhaled iloprost as a bridge to heart transplantation in a patient with endomyocardial fibroelastosis and severe pulmonary hypertension
Background: Endomyocardial fibrosis (EMF) is an endemic disease which can lead to partial obliteration of one or both ventricles with decreased ventricular distensibility and impaired diastolic filling. Results: We describe the intra- and postoperative course of an 18-year-old female patient undergoing orthotopic heart transplantation (HTx) because of EMF. Her body surface area was 1.18 m2. Blood pressure was 106/63mmHg during paroxysmal atrial fibrillation. She continously received an i.v. medication of 5µg/kg/min dopamine and 0.75µg/kg/min milrinone. Pulmonalis catheter examination revealed a PA of 83/39mmHg; mean pulmonary artery pressure (PAP) was 53mmHg; post-capillary wedge pressure was 15mmHg; trans-pulmonary gradient was 38mmHg; pulmonary vascular resistance (PVR) was 1113 dyn, systemic vascular resistance (SVR) was 2051 dyn. She received 50µg/day inhaled iloprost (Ilomedin®). This therapy was able to keep the preoperative PVR/SVR ratio below 30%. On day 33 of her hospitalisation, HTx was performed. Postoperative hemodynamics and respiratory conditions were stable without inhaled iloprost or nitric oxide. On postoperative day 3, however, iloprost therapy had to be restarted because of an increase in PAP levels. On postoperative day 24, the patient was discharged. Iloprost therapy was continued for additional 2 months then stopped since right heart catheter examination revealed hemodynamics within normal ranges and routine biopsy was grade 0. Conclusion: Inhaled iloprost, a long-acting prostacyclin analogue, can ameliorate pulmonary hypertension very successfully. In this case inhaled iloprost therapy was able to avoid the previously considered combined heart-lung transplantation. The 1-year follow data demonstrate the complete disappearance of pulmonary hypertension.
- 16 November 2005
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 53 (S 3) , P_6
Inhaled iloprost as a bridge to heart transplantation in a patient with endomyocardial fibroelastosis and severe pulmonary hypertension
Background: Endomyocardial fibrosis (EMF) is an endemic disease which can lead to partial obliteration of one or both ventricles with decreased ventricular distensibility and impaired diastolic filling. Results: We describe the intra- and postoperative course of an 18-year-old female patient undergoing orthotopic heart transplantation (HTx) because of EMF. Her body surface area was 1.18 m2. Blood pressure was 106/63mmHg during paroxysmal atrial fibrillation. She continously received an i.v. medication of 5µg/kg/min dopamine and 0.75µg/kg/min milrinone. Pulmonalis catheter examination revealed a PA of 83/39mmHg; mean pulmonary artery pressure (PAP) was 53mmHg; post-capillary wedge pressure was 15mmHg; trans-pulmonary gradient was 38mmHg; pulmonary vascular resistance (PVR) was 1113 dyn, systemic vascular resistance (SVR) was 2051 dyn. She received 50µg/day inhaled iloprost (Ilomedin®). This therapy was able to keep the preoperative PVR/SVR ratio below 30%. On day 33 of her hospitalisation, HTx was performed. Postoperative hemodynamics and respiratory conditions were stable without inhaled iloprost or nitric oxide. On postoperative day 3, however, iloprost therapy had to be restarted because of an increase in PAP levels. On postoperative day 24, the patient was discharged. Iloprost therapy was continued for additional 2 months then stopped since right heart catheter examination revealed hemodynamics within normal ranges and routine biopsy was grade 0. Conclusion: Inhaled iloprost, a long-acting prostacyclin analogue, can ameliorate pulmonary hypertension very successfully. In this case inhaled iloprost therapy was able to avoid the previously considered combined heart-lung transplantation. The 1-year follow data demonstrate the complete disappearance of pulmonary hypertension.
- 1 January 2002
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (1) , 125-126
Resynchronization therapy in patients with LBBB and end stage heart failure: real alternative or bridging to cardiac transplantation?
- 1 January 2002
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (1) , 125-126
Resynchronization therapy in patients with LBBB and end stage heart failure: real alternative or bridging to cardiac transplantation?
- 1 January 2001
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 46 (s1) , 170-171
BI-/LINKSVENTRIKULÄRE STIMULATION BEI SCHWERER HERZINSUFFIZIENZ: EINE ALTERNATIVE ZUR HERZTRANSPLANTATION?
- 1 January 2001
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 46 (s1) , 170-171
BI-/LINKSVENTRIKULÄRE STIMULATION BEI SCHWERER HERZINSUFFIZIENZ: EINE ALTERNATIVE ZUR HERZTRANSPLANTATION?
- Open Access
- 1 June 2000
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 2 (S1) , 104-105
Biventricular Pacemaker Stimulation in Advanced Congestive Heart Failure — Single Center Experience
- 1 June 2000
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 2 (S1) , 104-105
Open AccessBiventricular Pacemaker Stimulation in Advanced Congestive Heart Failure — Single Center Experience
- Open Access
- 1 June 2000
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 2 (S1) , 70
Changes of the Threshold of Left Ventricular (LV) Leads
- 1 June 2000
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 2 (S1) , 70
Open AccessChanges of the Threshold of Left Ventricular (LV) Leads
- 1 June 2000
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 2 (S1) , 69-70
Complications During Implantation of Coronary Vein (CV) Electrodes
- 1 June 2000
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 2 (S1) , 69-70
Complications During Implantation of Coronary Vein (CV) Electrodes